Evidence-based supplements, vitamins, minerals, nootropics, and longevity interventions
217 articoli
Riboflavin (vitamin B2) inhibits Cryptococcus neoformans growth, dismantles biofilms, and reduces organ fungal burden in mouse models of meningitis and pneumonia.
Le recensioni degli esperti confermano che NR e NMN aumentano i livelli di NAD+ nel sangue, ma le prove sulla longevità restano sfuggenti e la qualità dei prodotti varia enormemente.
Un'analisi pubblicata su JAMA rivela come i peptidi iniettabili illeciti stiano sfuggendo alla regolamentazione, mentre il confine tra medicina e potenziamento delle prestazioni si fa sempre più sfumato.
Dr. Abud Bakri covers BPC-157, epithalon, GHK-Cu, GLP-1s, and growth hormone peptides — separating real evidence from hype.
Both NMN and NR raise NAD+ levels in humans, but clinical proof of anti-aging benefits is still lacking — and product quality varies widely.
Attia lays out a rigorous, personalized decision framework for evaluating medications and supplements — cutting through hype with evidence hierarchy and risk math.
A candid breakdown of top NAD+ booster brands reveals strong biomarker data but slim evidence for real longevity outcomes.
A double-blind RCT finds daily spermidine supplementation reverses immune senescence markers and boosts vaccine antibody responses in adults over 65.
A 2026 comparative review of leading NAD+ supplements reveals NR has stronger human data, while NMN marketing often outpaces clinical proof.
A completed RCT tests whether adding collagen peptides to standard calcium and vitamin D supplementation improves bone density and remodeling markers in women with osteopenia.
Baylor researchers investigated whether glutathione precursors glycine and NAC could reverse oxidative stress and mitochondrial dysfunction in COVID-19.
Expert reviews compare NMN and NR head-to-head. NMN edges out for muscle and sleep benefits; NR leads for neuroprotection.
